These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 9231925)

  • 21. Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Hesselius P; Larsson A; Lamberg K; Wernlund J; Brodin O; Wagenius G
    Lung Cancer; 2002 Jul; 37(1):57-63. PubMed ID: 12057868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosus.
    Robak E; Woźniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Lupus; 2002; 11(6):348-55. PubMed ID: 12139372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer.
    Landriscina M; Cassano A; Ratto C; Longo R; Ippoliti M; Palazzotti B; Crucitti F; Barone C
    Br J Cancer; 1998 Sep; 78(6):765-70. PubMed ID: 9743297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi.
    Waltham M; Burnand KG; Collins M; Smith A
    J Vasc Surg; 2000 Nov; 32(5):988-96. PubMed ID: 11054231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent expression of serum vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in patients with carcinoma and sarcoma.
    Linder C; Linder S; Munck-Wikland E; Strander H
    Anticancer Res; 1998; 18(3B):2063-8. PubMed ID: 9677468
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
    Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
    Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
    Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
    Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival.
    Ugurel S; Rappl G; Tilgen W; Reinhold U
    J Clin Oncol; 2001 Jan; 19(2):577-83. PubMed ID: 11208853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M; Lennernäs B; Larsson A; Kälkner KM
    Anticancer Res; 2001; 21(2B):1423-9. PubMed ID: 11396226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of angiogenesis stimulators in children with solid malignancies.
    Pavlakovic H; Von Schütz V; Rössler J; Koscielniak E; Havers W; Schweigerer L
    Int J Cancer; 2001 Jun; 92(5):756-60. PubMed ID: 11340583
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated circulating levels of basic fibroblast growth factor and vascular endothelial growth factor in patients with acute myocardial infarction.
    Tamura K; Nakajima H; Rakue H; Sasame A; Naito Y; Nagai Y; Ibukiyama C
    Jpn Circ J; 1999 May; 63(5):357-61. PubMed ID: 10943614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiogenic factor VEGF is decreased in human colorectal neoplasms showing DNA microsatellite instability.
    Wynter CV; Simms LA; Buttenshaw RL; Biden KG; Young J; Leggett BA; Conrad RJ; Schoch EM; Jass JR; Praga Pillay S
    J Pathol; 1999 Nov; 189(3):319-25. PubMed ID: 10547592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesis.
    Braybrooke JP; O'Byrne KJ; Propper DJ; Blann A; Saunders M; Dobbs N; Han C; Woodhull J; Mitchell K; Crew J; Smith K; Stephens R; Ganesan TS; Talbot DC; Harris AL
    Clin Cancer Res; 2000 Dec; 6(12):4697-704. PubMed ID: 11156222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-binding angiogenic factors (basic fibroblast growth factor and vascular endothelial growth factor) in early neonatal life.
    Malamitsi-Puchner A; Tziotis J; Protonotariou E; Xyni K; Sarandakou A; Creatsas G
    Pediatr Res; 1999 Jun; 45(6):877-80. PubMed ID: 10367782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
    Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low hemoglobin is associated with increased serum levels of vascular endothelial growth factor (VEGF) in cancer patients. Does anemia stimulate angiogenesis?
    Dunst J; Pigorsch S; Hänsgen G; Hintner I; Lautenschläger C; Becker A
    Strahlenther Onkol; 1999 Mar; 175(3):93-6. PubMed ID: 10093609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis and angiogenic growth factors in Wilms tumor.
    Sköldenberg EG; Christiansson J; Sandstedt B; Larsson A; Läckgren G; Christofferson R
    J Urol; 2001 Jun; 165(6 Pt 2):2274-9. PubMed ID: 11371962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum vascular endothelial growth factor is often elevated in disseminated cancer.
    Salven P; Mänpää H; Orpana A; Alitalo K; Joensuu H
    Clin Cancer Res; 1997 May; 3(5):647-51. PubMed ID: 9815732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum leptin, prolactin and vascular endothelial growth factor (VEGF) levels in patients with breast cancer.
    Coskun U; Günel N; Toruner FB; Sancak B; Onuk E; Bayram O; Cengiz O; Yilmaz E; Elbeg S; Ozkan S
    Neoplasma; 2003; 50(1):41-6. PubMed ID: 12687277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma.
    Balsari A; Maier JA; Colnaghi MI; Ménard S
    Lab Invest; 1999 Jul; 79(7):897-902. PubMed ID: 10418830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.